What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

27 citing papers in PubMed.

1. Integrative in silico and in vitro screening of small molecules targeting RNA.Current protocols · 2026
   Article
2. Rapid Fragment Screening byAngewandte Chemie (International ed. in English) · 2026
   Article
3. RNA functional modulation by Mitoxantrone via RNA structural ensemble repartitioning.Nature communications · 2026
   Article
4. NMR-Based Fragment Screening for RNA-Targeted Drug Discovery.Molecules (Basel, Switzerland) · 2026
   Review
5. EstablishingAnalytical chemistry · 2026
   Article
6. WRN structural flexibility showcased through fragment-based lead discovery of inhibitors.Nature communications · 2026
   Article
7. Streamlined Fragment-Based Discovery Platform for Targeting Structured RNAs.ACS chemical biology · 2025
   Article
8. Structure-informed design of an ultrabright RNA-activated fluorophore.Nature chemistry · 2025
   Article
9. Electrostatic Anchoring in RNA-Ligand Design─Dissecting the Effects of Positive Charges on Affinity, Selectivity, Binding Kinetics, and Thermodynamics.Journal of medicinal chemistry · 2025
   Article
10. The Druggable Transcriptome Project: From Chemical Probes to Precision Medicines.Biochemistry · 2025
    Review
11. DRLiPS: a novel method for prediction of druggable RNA-small molecule binding pockets using machine learning.Nucleic acids research · 2025
    Article
12. Perspectives on Applications ofMolecules (Basel, Switzerland) · 2024
    Review
13. Structure-based virtual screening of unbiased and RNA-focused libraries to identify new ligands for the HCV IRES model system.RSC medicinal chemistry · 2024
    Article
14. NMRRSC medicinal chemistry · 2024
    Article
15. Fragment-Based Approaches to Identify RNA Binders.Journal of medicinal chemistry · 2023
    Review
16. Innovations in targeting RNA by fragment-based ligand discovery.Current opinion in structural biology · 2023
    Review
17. Contemporary Progress and Opportunities in RNA-Targeted Drug Discovery.ACS medicinal chemistry letters · 2023
    Review
18. Low-Molecular Weight Small Molecules Can Potently Bind RNA and Affect Oncogenic Pathways in Cells.Journal of the American Chemical Society · 2022
    Article
19. Modulation of Host-Parasite Interactions with Small Molecules TargetingACS infectious diseases · 2022
    Article
20. Pharmacophore-Based Discovery of Viral RNA Conformational Modulators.Pharmaceuticals (Basel, Switzerland) · 2022
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

26 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as